Previous close | 12.33 |
Open | 12.38 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 12.23 - 12.41 |
52-week range | 10.18 - 18.19 |
Volume | |
Avg. volume | 113,709 |
Market cap | 25.986B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 39.48 |
EPS (TTM) | 0.31 |
Earnings date | N/A |
Forward dividend & yield | 0.28 (2.33%) |
Ex-dividend date | 13 May 2022 |
1y target est | N/A |
COPENHAGEN (Reuters) -Shares in Coloplast rose on Monday after the medical equipment maker said it had agreed a 2.16 billion euros ($2.49 billion) deal to buy Atos Medical, which specialises in laryngectomy, from French private equity firm PAI Partners. "Atos Medical represents a new long-term growth category for Coloplast," Coloplast said in a statement. Shares in Coloplast were trading 3.6% higher at 0831 GMT at the highest level since mid-September.